- ￥1700
- GeneTex
- 美国
- GTX125928-S
- 2026年02月26日
- ELISA,WB,IHC等
- rabbit/mouse
- human/mouse/rat等
企业认证
相关产品推荐更多 >
![Parathyroid Hormone antibody [105G7]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
![CCDC90B antibody [N1C2]](https://img1.dxycdn.com/2023/0516/045/6925717576889828561-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
请参考说明
- 亚型：
请参考说明
- 形态：
液体
- 保存条件：
Aliquot and store at -20ºC
- 克隆性：
请参考说明
- 标记物：
请参考说明
- 适应物种：
human/mouse/rat等
- 保质期：
请参考说明
- 级别：
科研用
- 库存：
少量现货
- 供应商：
欣博盛生物
- 宿主：
rabbit/mouse
- 应用范围：
ELISA,WB,IHC等
- 浓度：
请参考说明
- 靶点：
请参考说明
- 抗体英文名：
Influenza A virus M1 (matrix protein) antibody
- 抗体名：
Influenza A virus M1 (matrix protein) antibody
- 规格：
25μl
Influenza A virus M1 (matrix protein) antibody产品货号是GTX125928，有100 μl和25 μl两种规格可供选择。如需购买Genetex公司产品，请联系Genetex国内总代理商欣博盛生物。热销品常备现货~
形式
Liquid
存储溶液
PBS, 20% Glycerol
存放说明
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
浓度
0.76 mg/ml (Please refer to the vial label for the specific concentration.)
免疫原种属
Influenza A virus
免疫原
Recombinant protein encompassing a sequence within the C-terminus region of Influenza A virus M1 (matrix protein) (A/Puerto Rico/8/1934(H1N1). The exact sequence is proprietary.
纯化方式
Purified by antigen-affinity chromatography.
偶联
Unconjugated
RRID
AB_11171466
注意事项
仅供实验室使用。不适用于人类或动物的任何临床，治疗或诊断用途。不适合动物或人类食用。
GeneTex公司于1997年成立于美国得克萨斯州的圣安东尼奥（现已迁至南加州），是由三位国际知名的科学家创立（其中一名科学家发现人类第一个抑癌基因-Rb基因 ），公司致力于开发各种基础医学相关的新型研究用抗体。公司起初的核心目标在于协助科学家寻找引发人类乳腺癌的分子新靶标，现在已经逐步扩展到其他研究领域的新抗体开发和配套诊断试剂上。至今，GeneTex抗体所含盖的领域从神经学、血液血管学、免疫学、代谢机制、细胞信号传导、研究、老化、遗传学、感染疾病诊断与研究，乃至于斑马鱼模式动物抗体等，并提供完善的客制化抗体制备服务。GeneTex 公司曾与多家著名抗体公司合作业务，有优秀的科学家及生物信息专家设计抗原，并利用100% 抗原亲和纯化方式纯化制备，有效提升抗体的专一性。目前该公司拥有的抗体总数已逾55,000种，而且每月仍有近百种新型抗体推出。其中，以小鼠单株抗体与兔多株抗体为该公司最具质量与价格优势的产品。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Zhang X et al. Biology (Basel) 2025; 14 (12) Targeted NanoBiT Screening Identifies a Novel Interaction Between SNAPIN and Influenza A Virus M1 Protein.
Zhang X et al. Biology 2025; 14 (12) : 1770 Targeted NanoBiT Screening Identifies a Novel Interaction Between SNAPIN and Influenza A Virus M1 Protein
J Huang et al. J Virol 2025; : e0189325 The viral proteins of influenza A virus competitively bind to TRIM31 with MAVS to fine-tune the antiviral innate immunity
Nakano M et al. J Virol 2025; 99 (10) : e0073725 Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.
Wang X et al. PLoS Pathog 2025; 21 (10) : e1013511 TfR1 facilitates influenza virus endocytosis and uncoating by interacting with NA and M1 via extracellular and intracellular domains.
Wang T et al. Front Cell Infect Microbiol 2025; 15 : 1647283 CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA.
Jiang M et al. Adv Sci (Weinh) 2025; 12 (28) : e2417318 Adducin-1 Facilitates Influenza Virus Endosomal Trafficking and Uncoating by Regulating Branched Actin Dynamics and Myosin IIB Activity.
Yang X et al. Front Microbiol 2025; 16 : 1600935 Screening kinase inhibitors identifies MELK as a prime target against influenza virus infections through inhibition of viral mRNA splicing.
Ahmad S et al. Nucleic Acids Res 2025; 53 (11) Visualizing the transcription and replication of influenza A viral RNAs in cells by multiple direct RNA padlock probing and in situ sequencing (mudRapp-seq).
J Dai et al. J Virol 2025; : e0189424 Dexamethasone disrupts intracellular pH homeostasis to delay coronavirus infectious bronchitis virus cell entry via sodium hydrogen exchanger 3 activation
G Wang et al. mBio 2025; : e0019425 Cellular SLC35B4 promotes internalization during influenza A virus entry
Xia B et al. Am J Physiol Heart Circ Physiol 2024; 327 (4) : H937-H946 FBXL19 in endothelial cells protects the heart from influenza A infection by enhancing antiviral immunity and reducing cellular senescence programs.
Ouyang A et al. Adv Sci (Weinh) 2024; 11 (39) : e2404365 The Hemagglutinin of Influenza A Virus Induces Ferroptosis to Facilitate Viral Replication.
Wang Y et al. Vet Res 2024; 55 (1) : 121 LINC01197 inhibits influenza A virus replication by serving as a PABPC1 decoy.
Cao L et al. Emerg Microbes Infect 2024; 13 (1) : 2387910 Inhibition of RAN attenuates influenza a virus replication and nucleoprotein nuclear export.
Expression of the Hemagglutinin Protein of Influenza Virus: Analysis of Protein Modifications
the capacity of this system to direct the complex and posttranslational modifications involved in the biosynthesis of most membrane and secretory proteins. To probe this question, the influenza virus hemagglutinin was expressed in Spodupteru frugiperdu (Sf
An Immunoproteomics Approach to Screen the Antigenicity of the Influenza Virus
The structure and antigenicity of protein antigens of the influenza virus are screened in a single step employing an immunoproteomics approach. Matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) coupled to gel
This chapter describes some commonly used methods of influenza virus titration, antigenic characterization, and serological methods by antibody detection. These methods are essential not only for virus characterization
技术资料暂无技术资料 索取技术资料
